By Ben Butkus

Biotech firm ZyGem and pharmacogenomic assay developer Genomic Health each said this week that they have developed methods for extracting all of the RNA from samples for downstream testing and analysis.

ZyGem's method, which is available as a commercial RNA-extraction kit called RNAGem, involves a single-tube, rapid extraction of RNA from lysed cells. ZyGem said that the method can prepare samples in under 20 minutes, or up to ten times faster than existing RNA extraction products.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.